Jaguar Health (JAGX) BidaskScore is downgraded to Strongly Sold

Jaguar Health, Inc.

The BidaskScore of Jaguar Health Inc. JAGXJAGX shows that the shares of the company are now JAGXStrongly Bought Strongly Sold by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Strongly Sold since October 1.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Jaguar Health, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.